Endovascular Today15h
Akura’s Receives IDE Approval for QUADRA-PE Pivotal Trial of Katana System
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...
Endovascular Today15h
Akura Receives IDE Approval for QUADRA-PE Pivotal Trial of Katana System
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...
Endovascular Today1d
CVRx Barostim Procedure Assigned CMS New Technology Outpatient Payment
CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...
Endovascular Today8d
CMS Grants TPT Payment for Medtronic’s Symplicity Spyral RDN and Recor’s Paradise uRDN Systems
Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...
Endovascular Today5d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
Endovascular Today5d
CLOUT Registry’s 2-Year Outcomes Reported for Inari’s ClotTriever to Treat DVT
Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient ...
Endovascular Today6d
Study Assesses Effects of Intravascular Volume Expansion on Deep Pelvic Vein Size
A study assessed the effects of intravascular volume expansion on deep pelvic vein size using the 200-150-125 rule for the ...
Endovascular Today6d
Philips’ Duo Venous Stent System Studied in VIVID Trial at 24 Months
The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system ...
Endovascular Today6d
Medtronic’s VenaSeal Closure Compared to Surgical Stripping in 6-Month Data
Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...
Endovascular Today2d
LIFE-BTK Trial Implemented Several Enrollment Initiatives to Facilitate Inclusion of Diverse Populations
In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...
Endovascular Today5d
PERFORMANCE II Evaluates Contego’s Neuroguard IEP Carotid Stent System at 2 Years
The safety and effectiveness of the Neuroguard IEP (Contego Medical)—a three-in-one carotid stent system with integrated ...
Endovascular Today4d
DEEPER OUS 2-Year Data Assess Reflow’s Spur Retrievable Spur System Combined With Paclitaxel DCB
DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...